Japan· JP-4490033F2113

ビラスチン

A bilastin product containing ビラスチン, registered in Japan by 日新製薬(山形), on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

On Japan’s NHI price listATC R06AX29

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedビラスチンATCR06AX29REGISTER NO.JP-4490033F2113PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Bilastin is registered in 11 of 19 countries.

Countries holding a registration under ATC R06AX29 (bilastin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 7 of them publish a price we can compare per daily dose

Bilastin · ATC R06AX29

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bilastin costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.14 in France to $0.45 in Switzerland — a ×3.3 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Bilastin · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.45
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ビラスチン
Manufacturer
日新製薬(山形)
Country
Japan (JP)
ATC code
R06AX29
ATC class
Bilastin
Defined daily dose
20 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c96bc3eb-9fb0-42d7-901f-c14bae682a8c
GET /v1/drugs/c96bc3eb-9fb0-42d7-901f-c14bae682a8c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "20mg1錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "4490033F2113",
  "category": "内用薬",
  "price_yen": 14859,
  "generic_name": "ビラスチン",
  "product_name_jp": null,
  "therapeutic_class": "4490",
  "transitional_expiry": "14859"
}

See everything about bilastin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.